These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3182462

  • 1. The effect of ofloxacin on the intracellular growth of Legionella pneumophila in guinea pig alveolar phagocytes.
    Fitzgeorge RB, Featherstone AS, Baskerville A.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():53-7. PubMed ID: 3182462
    [Abstract] [Full Text] [Related]

  • 2. The effect of antibiotics on the growth of Legionella pneumophila in guinea-pig alveolar phagocytes infected in vivo by an aerosol.
    Fitzgeorge RB.
    J Infect; 1985 May; 10(3):189-93. PubMed ID: 3161953
    [Abstract] [Full Text] [Related]

  • 3. In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia.
    Edelstein PH, Edelstein MA, Lehr KH, Ren J.
    J Antimicrob Chemother; 1996 Jan; 37(1):117-26. PubMed ID: 8647752
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Edelstein MA, Weidenfeld J, Dorr MB.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
    [Abstract] [Full Text] [Related]

  • 5. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE, Arnold B, Yu VL.
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia.
    Edelstein PH, Edelstein MA.
    Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571
    [Abstract] [Full Text] [Related]

  • 7. The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs.
    Saito A, Koga H, Shigeno H, Watanabe K, Mori K, Kohno S, Shigeno Y, Suzuyama Y, Yamaguchi K, Hirota M.
    J Antimicrob Chemother; 1986 Aug; 18(2):251-60. PubMed ID: 3759736
    [Abstract] [Full Text] [Related]

  • 8. Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Weiss WJ, Edelstein MA.
    Antimicrob Agents Chemother; 2003 Feb; 47(2):533-40. PubMed ID: 12543655
    [Abstract] [Full Text] [Related]

  • 9. Review of azithromycin activity against Legionella spp.
    Edelstein PH.
    Pathol Biol (Paris); 1995 Jun; 43(6):569-72. PubMed ID: 8539085
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F, Arakaki N, Tateyama M, Koide M, Shinzato T, Kawakami K, Saito A.
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [Abstract] [Full Text] [Related]

  • 11. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
    Kohno S, Koga H, Yamaguchi K, Masaki M, Inoue Y, Dotsu Y, Masuyama Y, Hayashi T, Hirota M, Saito A.
    J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201
    [Abstract] [Full Text] [Related]

  • 12. Effect of human urinary colony-stimulating factor on experimental Legionella pneumophila infection in guinea pigs.
    Owan I, Saito A.
    J Antimicrob Chemother; 1990 Dec; 26(6):831-40. PubMed ID: 1964449
    [Abstract] [Full Text] [Related]

  • 13. Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.
    Stamler DA, Edelstein MA, Edelstein PH.
    Antimicrob Agents Chemother; 1994 Feb; 38(2):217-22. PubMed ID: 8192446
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
    Edelstein PH, Shinzato T, Doyle E, Edelstein MA.
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
    [Abstract] [Full Text] [Related]

  • 18. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    Edelstein PH, Shinzato T, Edelstein MA.
    J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of severe respiratory infection. Legionella pneumonia].
    Saito A.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):281-5. PubMed ID: 2615084
    [Abstract] [Full Text] [Related]

  • 20. Studies on ciprofloxacin therapy of experimental Legionnaires' disease.
    Fitzgeorge RB, Gibson DH, Jepras R, Baskerville A.
    J Infect; 1985 May; 10(3):194-203. PubMed ID: 3161954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.